End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,260 KRW | -0.15% | -2.69% | +0.15% |
Business Summary
Number of employees: 236
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Trial Agencies
71.9
%
| 32,200 | 82.8 % | 34,424 | 71.9 % | +6.90% |
Medical Consulting
31.6
%
| 7,250 | 18.6 % | 15,142 | 31.6 % | +108.86% |
Inter-Sector Transactions
-3.6
%
| -577 | -1.5 % | -1,721 | -3.6 % | +198.48% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 38,874 | 100.0 % | 47,844 | 100.0 % | +23.08% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kyung-Sun Gong
CEO | Chief Executive Officer | 56 | - |
Tae-Sik Yang
DFI | Director of Finance/CFO | 55 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kyung-Sun Gong
CEO | Chief Executive Officer | 56 | - |
Nam-Hoon Kim
BRD | Director/Board Member | 43 | - |
Tae-Sik Yang
DFI | Director of Finance/CFO | 55 | - |
Lee-Woo Jia
BRD | Director/Board Member | 56 | - |
Jen Wen
BRD | Director/Board Member | 56 | - |
Tae-Wook Yang
BRD | Director/Board Member | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,709,280 | 6,675,968 ( 28.16 %) | 0 | 28.16 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DREAMCIS, INC. 2.76% | 655,076 | 2.76% | 1,426,657 $ |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+0.15% | 55.89M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
-2.98% | 2.64B | |
+2.72% | 2.63B | |
-46.17% | 2.16B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B | |
+20.41% | 999M |
- Stock Market
- Equities
- A223250 Stock
- Company DreamCIS, Inc.